Drugs in MeSH Category Adrenergic alpha-2 Receptor Antagonists
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms Usa | LURASIDONE HYDROCHLORIDE | lurasidone hydrochloride | TABLET;ORAL | 208060-004 | May 17, 2019 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aurobindo Pharma Ltd | LURASIDONE HYDROCHLORIDE | lurasidone hydrochloride | TABLET;ORAL | 208045-002 | Mar 10, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Aurobindo Pharma Ltd | LURASIDONE HYDROCHLORIDE | lurasidone hydrochloride | TABLET;ORAL | 208045-001 | Mar 10, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
